TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 7 filers reported holding TRICIDA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4 | -100.0% | 23,126 | -0.2% | 0.00% | – |
| Q3 2022 | $243,000 | +9.5% | 23,165 | +1.2% | 0.00% | – |
| Q2 2022 | $222,000 | +22100.0% | 22,900 | +9481.6% | 0.00% | – |
| Q2 2021 | $1,000 | -99.0% | 239 | -98.7% | 0.00% | – |
| Q1 2021 | $96,000 | -24.4% | 18,058 | 0.0% | 0.00% | – |
| Q4 2020 | $127,000 | -93.9% | 18,058 | -92.2% | 0.00% | -100.0% |
| Q3 2020 | $2,093,000 | -67.0% | 231,063 | 0.0% | 0.00% | -62.5% |
| Q2 2020 | $6,350,000 | +198.7% | 231,063 | +139.1% | 0.01% | +166.7% |
| Q1 2020 | $2,126,000 | +186.5% | 96,641 | +391.6% | 0.00% | +200.0% |
| Q4 2019 | $742,000 | +7.5% | 19,658 | -12.1% | 0.00% | 0.0% |
| Q3 2019 | $690,000 | -21.8% | 22,358 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $882,000 | +72.3% | 22,358 | +68.6% | 0.00% | 0.0% |
| Q1 2019 | $512,000 | +142.7% | 13,258 | +48.0% | 0.00% | – |
| Q4 2018 | $211,000 | – | 8,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |